Noninvasive prenatal testing (NIPT) in twin pregnancies with treatment of assisted reproductive techniques (ART) in a single center

Prenatal Diagnosis

Volumn 36, Issue 7, 2016, Pages 672-679

  Tan, Yueqiu ^a,b,c   Gao, Ya ^d   Lin, Ge ^a,b,c   Fu, Meili ^d   Li, Xihong ^c   Yin, Xuyang ^d   Du, Juan ^a,b,c   Li, Jing ^e   Li, Wen ^a,b,c   Peng, Huanhuan ^e   Yuan, Yuying ^d   Chen, Fang ^d,f   Jiang, Fuman ^d   Zhang, Hongyun ^d   Lu, Guangxiu ^b,c   Gong, Fei ^a,b,c   Wang, Wei ^d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c Reproductive and Genetic Hospital of Citic Xiangya   (China)

^d BGI SHENZHEN   (China)

^e Clinical Laboratory of BGI Health   (China)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINESE; FALSE NEGATIVE RESULT; FEMALE; FERTILIZATION IN VITRO; FETUS; FOLLOW UP; HUMAN; INFERTILITY THERAPY; INFORMATION; KARYOTYPING; MAJOR CLINICAL STUDY; MATERNAL PLASMA; NONINVASIVE PRENATAL TESTING; OBSTETRIC DELIVERY; PHENOTYPE; PREDICTIVE VALUE; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TRISOMY 13; TRISOMY 18; TRISOMY 21; TWIN PREGNANCY;

EID: 84978943432     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4837     Document Type: Article

References (48)

1. Andersen AN, Goossens V, Gianaroli L, et al. Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Hum Reprod 2007;22(6):1513–25.
2. Sunderam S, Kissin DM, Flowers L, et al. Assisted reproductive technology surveillance--United States, 2009. MMWR Surveill Summ 2012;61(7):1–23.
3. Yang X, Li Y, Li C, Zhang W. Current overview of pregnancy complications and live-birth outcome of assisted reproductive technology in mainland China. Fertil Steril 2014;101(2):385–91.
4. Luke B, Brown MB, Grainger DA, et al. Practice patterns and outcomes with the use of single embryo transfer in the United States. Fertil Steril 2010;93(2):490–8.
5. Nyboe Andersen A, Goossens V, Bhattacharya S, et al. Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 2009;24(6):1267–87.
6. Pinborg A. IVF/ICSI twin pregnancies: risks and prevention. Hum Reprod Update 2005;11(6):575–93.
7. Gjerris AC, Loft A, Pinborg A, et al. Prenatal testing among women pregnant after assisted reproductive techniques in Denmark 1995–2000: a national cohort study. Hum Reprod 2008;23(7):1545–52.
8. Gjerris AC, Loft A, Pinborg A, et al. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol 2009;33(1):8–17.
9. Radojcic Badovinac A, Buretic-Tomljanovic A, Starcevic N, et al. Chromosome studies in patients with defective reproductive success. Am J Reprod Immunol 2000;44(5):279–83.
10. Gjerris AC, Tabor A, Loft A, et al. First trimester prenatal screening among women pregnant after IVF/ICSI. Hum Reprod Update 2012;18(4):350–9.
11. Maymon R, Cuckle H, Svirsky R, et al. Nuchal translucency in twins according to mode of assisted conception and chorionicity. Ultrasound Obstet Gynecol 2014;44(1):38–43.
12. Barkai G, Goldman B, Ries L, et al. Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 1996;16(12):1111–4.
13. Engels MA, Kooij M, Schats R, et al. First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction. Prenat Diagn 2010;30(4):372–7.
14. Maymon R, Shulman A. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 2004;24(2):125–9.
15. Wald NJ, White N, Morris JK, et al. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Br J Obstet Gynaecol 1999;106(12):1304–6.
16. Hui PW, Lee CP, Tang MH, Ho PC. Nuchal translucency in pregnancies conceived after assisted reproduction technology. Curr Opin Obstet Gynecol 2006;18(3):319–24.
17. Linskens IH, Spreeuwenberg MD, Blankenstein MA, vanVugt JM. Early first-trimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins. Prenat Diagn 2009;29(1):74–8.
18. Orlandi F, Rossi C, Allegra A, et al. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 2002;22(8):718–21.
19. Raty R, Virtanen A, Koskinen P, et al. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies. Prenat Diagn 2000;20(3):221–3.
20. Ashoor G, Syngelaki A, Wagner M, et al. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206(4):322 e321–5.
21. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119(5):890–901.
22. Jiang F, Ren J, Chen F, et al. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics 2012;5:57.
23. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13(11):913–20.
24. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14(3):296–305.
25. Huang X, Zheng J, Chen M, et al. Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies. Prenat Diagn 2014;34(4):335–40.
26. Lau TK, Jiang F, Chan MK, et al. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med 2013;26(4):434–7.
27. Tan YQ, Tan K, Zhang SP, et al. Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers. Hum Reprod 2013;28(9):2581–92.
28. Lau TK, Cheung SW, Lo PS, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol 2014;43(3):254–64.
29. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn 2012;32(13):1225–32.
30. Zhang H, Gao Y, Jiang F, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol 2015;45(5):530–8.
31. Zhou Y, Zhu Z, Gao Y, et al. Effects of maternal and fetal characteristics on cell-free fetal DNA fraction in maternal plasma. Reprod Sci 2015;22(11):1429–35.
32. Canick JA, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012;32(8):730–4.
33. Bevilacqua E, Gil MM, Nicolaides KH, et al. Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies. Ultrasound Obstet Gynecol 2015;45(1):61–6.
34. Ben-Ami I, Maymon R, Svirsky R, et al. Down syndrome screening in assisted conception twins: an iatrogenic medical challenge. Obstet Gynecol Surv 2013;68(11):764–73.
35. Wald NJ, Rish S, Hackshaw AK. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies. Prenat Diagn 2003;23(7):588–92.
36. Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn 2000;20(2):91–5.
37. Daskalakis G, Anastasakis E, Papantoniou N, et al. Second trimester amniocentesis in assisted conception versus spontaneously conceived twins. Fertil Steril 2009;91(6):2572–7.
38. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27(1):1–7.
39. Abu-Musa AA, Nassar AH, Usta IM. Attitude of women with IVF and spontaneous pregnancies towards prenatal screening. Hum Reprod 2008;23(11):2438–43.
40. Gromminger S, Yagmur E, Erkan S, et al. Fetal aneuploidy detection by cell-free DNA sequencing for multiple pregnancies and quality issues with vanishing twins. J Clin Med 2014;3(3):679–92.
41. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33(6):569–74.
42. Porreco RP, Garite TJ, Maurel K, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol 2014;211(4):365 e361–12.
43. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370(9):799–808.
44. Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015;372(17):1589–97.
45. Lambers MJ, Mager E, Goutbeek J, et al. Factors determining early pregnancy loss in singleton and multiple implantations. Hum Reprod 2007;22(1):275–9.
46. Matias A, Oliveira C, daSilva JT, et al. The effect of ICSI, maternal age, and embryonic stage on early clinical loss rate of twin versus singleton pregnancies. Eur J Obstet Gynecol Reprod Biol 2007;130(2):212–5.
47. Tummers P, De Sutter P, Dhont M. Risk of spontaneous abortion in singleton and twin pregnancies after IVF/ICSI. Hum Reprod 2003;18(8):1720–3.
48. Wisborg K, Ingerslev HJ, Henriksen TB. IVF and stillbirth: a prospective follow-up study. Hum Reprod 2010;25(5):1312–6.